Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 13, 2012
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Aged (MeSH)
- Antithrombins (MeSH)
- Atrial Fibrillation (MeSH)
- Benzimidazoles (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Contraindications (MeSH)
- Dabigatran (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Erythrocyte Transfusion (MeSH)
- Half-Life (MeSH)
- Hematemesis (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Melena (MeSH)
- Plasma (MeSH)
- Risk Factors (MeSH)
- Stroke (MeSH)
- Time Factors (MeSH)
- Withholding Treatment (MeSH)
- beta-Alanine (MeSH)
published in
- Circulation Journal